16th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2009, Montreal

8 June 2009. Related: Conference reports, Conference index, CROI 16 (Retrovirus) 2009.

Abstracts and webcasts can be accessed via the conference website at the following link:

http://www.retroconference.org

HTB reports from the conference include:

• Assessing the cardiovascular impact of HIV, abacavir, and new signals for lopinavir/r

• Intensive smoking cessation programme reports limited success at 6 months

• HDL particle concentration predicts cardiovascular disease in SMART

• No effect of hormonal contraception on HIV disease progression in large multi-country cohort

• Pregnancy, family planning, and HIV acquisition in HPTN 039

• Progression and regression of pre-malignant cervical lesions in HIV-positive women from Soweto

• CD4 count >250 not predictive of rash-associated hepatotoxicity among women initiating nevirapine-based ART in Zambia, Thailand, and Kenya

• HIV testing of infants at immunisation clinics in Kwazulu-Natal

• Rapid HIV disease progression in South African infants co-infected with cytomegalovirus (CMV)

• Pharmacokinetic studies in very young infants

• Double-dose lopinavir/ritonavir provides insufficient lopinavir exposure in children receiving rifampicin

• PI-based ART in children with HIV and HIV/TB coinfection in South Africa

• Etravirine dose selection in children aged 6 to 17

• Preliminary results from first paediatric raltegravir study